Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > MD Providers

Dr. Nicholas A. Demonaco, MD

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

Temple University School of Medicine

Professional interests include: thyroid cancer, lymphatic diseases, bleeding disorders, and more.

8926 Woodyard Road Suite 201
Clinton, MD 20735

(301) 868-7911

Dr. Nicholas A. Demonaco, MD is a medical oncologist in Clinton, MD specializing in medical oncology, adult oncology and adult hematology. He graduated from Temple University School of Medicine. Dr. Nicholas A. Demonaco, MD is affiliated with University of Maryland Medical System, Luminis Health, MedStar Health, MedStar Southern Maryland Hospital Center and MARYLAND ONCOLOGY HEMATOLOGY PA.

Office Locations

7503 Surratts Road
Clinton, MD 20735

open_in_new

8926 Woodyard Road Suite 201
Clinton, MD 20735

(301) 868-7911

(301) 868-2285

open_in_new

University of Maryland Medical System

9333 Healthcare Way
Largo, MD 20774

(240) 677-8300

open_in_new

Some issues Dr. Nicholas A. Demonaco, MD can help you with:

Blood Transfusion

Blood transfusions typically treat those who experience a substantial loss of blood from an injury or surgical procedure, or those who suffer from conditions that alter the blood supply or blood components. For example, a blood transfusion may contribute additional red blood cells to someone with anemia, a condition where the body does not produce enough red blood cells. Other conditions may include:

Hemophilia (blood clotting disorder)
Leukemia
Liver disease
Sickle cell disease (misshapen red blood cells)
Thrombocytopenia (lack of platelets)

When a patient has sufficient blood volume and lacks one or more components, a complete blood count (CBC) test can help determine if a patient requires a transfusion by measuring four blood components: red blood cells, white blood cells, platelets, and hemoglobin. If any of the patient's component counts is significantly below a standard range, the patient will likely need a blood transfusion. The complete blood count test uses a needle to extract a small amount of blood for testing.

Blood transfusion recipients should be tested for their blood type, which is one of four different types: type A, B, AB, or O. Patients with A, B, and O blood can only receive a blood donation matching their blood type or of O blood, which is known as the universal donor. Those with AB blood are considered "universal recipients"; they may receive A, B, AB, or O blood. Further complicating blood types is the presence or absence of the RhD antigen, adding a positive or negative modifier that should also be considered. Incompatible blood donations may cause transfusion sickness, such as a hemolytic reaction, where the body fights the donated red blood cells.

In certain emergency or trauma situations, medical teams often do not perform a complete blood count (CBC) test or blood type test. In those cases, patients are often given O negative blood, which is universally accepted. Some patients have their blood type on a medical card or bracelet, allowing emergency medical teams to issue compatible blood without testing.

Transfusions are performed by inserting a needle attached to an intravenous line (IV) into a vein in the body. This IV line is attached to a bag of blood that steadily dispenses blood into the patient's bloodstream. The type, volume, and components of donated blood depend on the patient's condition and needs. After the transfusion is complete, patients are generally permitted to resume normal activity, unless prohibited by a condition or injury. Some patients may experience bruising or soreness around the area that the needle was inserted.

At times, a second complete blood count test is performed to determine if the transfusion has brought patients' component counts to normal levels. Some patients may require multiple blood transfusions to reach a healthy blood volume and blood component count.

Once patients' blood volumes and components reach sufficient levels, they will generally begin to feel better. Patients of all ages, from newborn infants to elderly adults, can receive a blood transfusion.

Breast Biopsy

Breast biopsy is a procedure where a small sample of tissue is collected from the breast for testing. A physician may prescribe a breast biopsy for a variety of reasons, but they are most frequently prescribed for a lump found in the breast. Biopsy samples extracted are examined by pathologists in a laboratory setting and are tested to determine if they are cancerous or benign, or indicative of some other condition. Depending on the lab results, physicians may prescribe additional treatment. Other circumstances which may prompt a breast biopsy include:

Mammograms that detect other unusual features in the chest, such as a cyst or calcium deposit
Breast scans or ultrasounds that display abnormalities
Nipple changes, such as scaling, crusting, or bloody discharge

Breast biopsies are collected through several different procedures and the specific type of biopsy that a patient receives depends on the size, location, and features of a breast lump or irregularity. The three main methods of collecting a breast biopsy include:

Fine needle aspiration (FNA biopsy), where a thin needle is directed into a breast lump or abnormality, extracting a small sample of tissue or liquid
Core needle biopsy (CNB biopsy), where a hollow needle is directed into a breast lump or abnormality, extracting cylinders of tissue called "cores"
Open (surgical) biopsy, where a breast lump is removed through an incision in the breast

Fine needle aspiration (FNA) and core needle biopsy (CNB) are sometimes image-guided, where a mammogram, ultrasound, or MRI helps direct the physician performing the needle extraction.

Fine needle aspiration, the most common biopsy method, generally requires few patient preparations. It is recommended patients avoid using lotion, deodorant, and perfume prior to their biopsy procedure. FNA biopsy is performed with local anesthesia (topical numbing cream) and typically has a quick recovery, but patients may experience soreness for a few days. Core needle biopsy extracts slightly more tissue than an FNA biopsy.

Open (surgical) biopsy is more invasive and requires general anesthesia, where patients are put to sleep during the procedure. Patients must fast prior to the surgery. After the biopsy is performed, patients are monitored in a recovery room for a time before being discharged, when they will need someone else to provide transportation.

Although some may consider breast biopsy to be a simple procedure, it can catch critical issues - particularly breast cancer - that impact wellness. If a breast biopsy reveals an underlying condition like life-threatening cancer, patients can receive the diagnosis and medical treatment that is necessary for their long-term health.

Hemophilia

Hemophilia is a bleeding disorder in which blood cannot clot normally. After an injury, people who have hemophilia bleed longer because they lack certain blood proteins that are responsible for clotting, called clotting factors. Some hemophiliacs are mildly deficient in this protein, so they bleed only when injured or after surgery. Those who are severely deficient, however, may experience symptoms of spontaneous bleeding, including the following:

Presence of blood in stool or urine
Frequent nosebleeds or large bruises
Unusual bleeding after being vaccinated
Pain, swelling, or tightness in joint

Most people with hemophilia have a family history of the disorder, though about 30% do not. The most common forms are hemophilia A (classic hemophilia) and hemophilia B (Christmas disease). Hemophilia A and B share certain characteristics, but different genes are involved. Acquired hemophilia is very rare and has been linked to autoimmune conditions, cancer, and multiple sclerosis.

Hemophilia may be diagnosed using a blood test. If there is family history of the disorder, testing may be done prenatally. Treatment involves regular intravenous replacement of clotting factors, which may be produced in a laboratory (recombinant) or come from blood donors. For people with milder forms of the disease, a hormone called desmopressin may stimulate the body to produce clotting factors. Other drug therapies include medications that help slow the breakdown of blood clots and medications that are applied directly to the wound to promote clotting.

Living with hemophilia can be challenging, but simple things may help prevent excessive bleeding. For example, choosing activities like walking or swimming over contact sports can prevent injuries and strengthen muscles while protecting the joints. Chances for bleeding may also be reduced by making sure that children wear helmets and elbow pads during activities like bicycle rides.

Noteworthy Medicare Patient Procedures Performed by Dr. Nicholas A. Demonaco, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Affordability:

IgD test

IgM test

quantitative Ig tests

total IgA test

total IgG test

In 2023, Dr. Nicholas A. Demonaco, MD had a list price for IgD test, IgM test, quantitative Ig tests, total IgA test, and total IgG test that was lower than the list prices billed to Medicare by 95% of providers in related specialties within Maryland. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Affordability:

hospital care

inpatient care

inpatient hospital care

In 2023, Dr. Nicholas A. Demonaco, MD had a list price for hospital care, inpatient care, and inpatient hospital care (for patient admitted to hospital) that was lower than the list prices billed to Medicare by 90% of providers in related specialties within Maryland. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

blood draw

lab tests

minimally invasive procedures

phlebotomy for lab tests

prothrombin time test

total IgA test

total IgG test

By Affordability:

CA-125 test

cancer antigen tests

carcinoembryonic antigen test

IgA test

IgG test

immunoglobulin tests

In 2012, among providers in related specialties within Maryland, Dr. Nicholas A. Demonaco, MD performed more blood draw, lab tests, minimally invasive procedures, phlebotomy for lab tests, prothrombin time (PT) test, total IgA test, and total IgG test procedures for Medicare patients than 75% of them and he also had a list price for CA-125 test, cancer antigen tests, carcinoembryonic antigen (CEA) test, IgA test, IgG test, and immunoglobulin tests that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2012 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	274
blood draw	1368
chemotherapy	274
doctor visit	1270
hormone therapy	18
hospital care	201
inpatient care	201
lab tests	14741
minimally invasive procedures	487
port flush	87
preventive care	45
vaccines	45

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2013 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	297
blood draw	1546
chemotherapy	297
doctor visit	1437
hormone therapy	29
hospital care	149
inpatient care	149
lab tests	14368
minimally invasive procedures	661
port flush	178
preventive care	41
vaccines	41

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	426
Female	768

**Ethnicity**
Non-Hispanic White	444
Black	716
Hispanic	14
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	541
From 75 to 84	384
85 and over	137
Less than 65	132

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2013

Hypertension	75
High Cholesterol	64
Stroke	7
Ischemic Heart Disease	40
Depression	12
Chronic Kidney Disease	50
Asthma	8
Osteoperosis	11
Atrial Fibrilation	10
Heart Failure	25
Chronic Obstructive Pulmonary Disease	16
Diabetes	49
Dementia	11
Cancer	36

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2014 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	267
blood draw	1007
chemotherapy	267
doctor visit	1218
hormone therapy	21
hospital care	196
inpatient care	196
lab tests	5677
minimally invasive procedures	474
port flush	137
preventive care	21
vaccines	21

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	372
Female	683

**Ethnicity**
Non-Hispanic White	346
Black	674
Hispanic	0
Asian	16
Other	0
Native American	0

**Age**
From 65 to 74	461
From 75 to 84	368
85 and over	108
Less than 65	118

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2014

Hypertension	75
High Cholesterol	61
Stroke	7
Ischemic Heart Disease	40
Depression	14
Chronic Kidney Disease	50
Asthma	9
Osteoperosis	9
Atrial Fibrilation	10
Heart Failure	26
Chronic Obstructive Pulmonary Disease	14
Diabetes	49
Dementia	11
Cancer	36

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2015 were lab tests, minimally invasive procedures, hospital care and inpatient care.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	187
chemotherapy	187
doctor visit	1120
hospital care	240
inpatient care	240
lab tests	3994
minimally invasive procedures	385
port flush	114

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	568
Female	1030

**Ethnicity**
Non-Hispanic White	518
Black	1040
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	684
From 75 to 84	524
85 and over	196
Less than 65	194

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2015

Hypertension	75
High Cholesterol	63
Stroke	6
Ischemic Heart Disease	39
Depression	15
Chronic Kidney Disease	50
Asthma	15
Osteoperosis	9
Atrial Fibrilation	12
Heart Failure	27
Chronic Obstructive Pulmonary Disease	18
Diabetes	51
Dementia	13
Cancer	38

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2016 were lab tests, minimally invasive procedures, hospital care and inpatient care.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	290
chemotherapy	290
doctor visit	1216
hospital care	331
inpatient care	331
lab tests	4644
minimally invasive procedures	439
port flush	110

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	287
Female	555

**Ethnicity**
Non-Hispanic White	248
Black	566
Hispanic	0
Asian	0
Other	11
Native American	0

**Age**
From 65 to 74	351
From 75 to 84	295
85 and over	99
Less than 65	97

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2016

Hypertension	75
High Cholesterol	64
Stroke	9
Ischemic Heart Disease	42
Depression	15
Chronic Kidney Disease	56
Asthma	22
Osteoperosis	7
Atrial Fibrilation	11
Heart Failure	27
Chronic Obstructive Pulmonary Disease	19
Diabetes	50
Dementia	15
Cancer	38

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2017 were lab tests, minimally invasive procedures, chemotherapy and biological response modifier (BRM) therapy.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	441
chemotherapy	441
doctor visit	1599
hospital care	369
inpatient care	369
lab tests	1955
minimally invasive procedures	625
port flush	129

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	322
Female	626

**Ethnicity**
Non-Hispanic White	292
Black	620
Hispanic	15
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	371
From 75 to 84	362
85 and over	115
Less than 65	100

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2017

Hypertension	75
High Cholesterol	58
Stroke	8
Ischemic Heart Disease	39
Depression	15
Chronic Kidney Disease	59
Asthma	11
Osteoperosis	9
Atrial Fibrilation	11
Heart Failure	27
Chronic Obstructive Pulmonary Disease	20
Diabetes	49
Dementia	14
Cancer	38

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2018 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	554
blood draw	773
chemotherapy	554
doctor visit	1722
hormone therapy	44
hospital care	276
inpatient care	276
lab tests	4838
minimally invasive procedures	748
port flush	95
thyroid function tests	23

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	349
Female	699

**Ethnicity**
Non-Hispanic White	299
Black	693
Hispanic	20
Asian	18
Other	18
Native American	0

**Age**
From 65 to 74	417
From 75 to 84	401
85 and over	116
Less than 65	114

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2018

Hypertension	75
High Cholesterol	67
Stroke	8
Ischemic Heart Disease	39
Depression	16
Chronic Kidney Disease	60
Asthma	10
Osteoperosis	9
Atrial Fibrilation	12
Heart Failure	29
Chronic Obstructive Pulmonary Disease	18
Diabetes	50
Dementia	15
Cancer	38

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	555
blood draw	1270
chemotherapy	555
doctor visit	1844
hormone therapy	29
hospital care	194
inpatient care	194
lab tests	6560
minimally invasive procedures	792
port flush	91
thyroid function tests	69

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	302
Female	665

**Ethnicity**
Non-Hispanic White	313
Black	605
Hispanic	21
Asian	12
Other	16
Native American	0

**Age**
From 65 to 74	386
From 75 to 84	366
85 and over	109
Less than 65	106

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2019

Hypertension	75
High Cholesterol	66
Stroke	7
Ischemic Heart Disease	37
Depression	17
Chronic Kidney Disease	57
Asthma	9
Osteoperosis	8
Atrial Fibrilation	10
Heart Failure	28
Chronic Obstructive Pulmonary Disease	16
Diabetes	49
Dementia	15
Cancer	38

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	623
blood draw	1693
chemotherapy	623
doctor visit	1784
hospital care	74
inpatient care	74
lab tests	6393
minimally invasive procedures	944
port flush	96
thyroid function tests	76

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	302
Female	688

**Ethnicity**
Non-Hispanic White	269
Black	669
Hispanic	18
Asian	17
Other	17
Native American	0

**Age**
From 65 to 74	396
From 75 to 84	371
85 and over	112
Less than 65	111

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2020

Hypertension	75
High Cholesterol	68
Stroke	8
Ischemic Heart Disease	37
Depression	17
Chronic Kidney Disease	55
Asthma	9
Osteoperosis	10
Atrial Fibrilation	11
Heart Failure	24
Chronic Obstructive Pulmonary Disease	14
Diabetes	46
Dementia	14
Cancer	37

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	574
blood draw	1873
chemotherapy	574
doctor visit	2005
hospital care	65
inpatient care	65
lab tests	7903
minimally invasive procedures	910
port flush	71
thyroid function tests	70

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	290
Female	685

**Ethnicity**
Non-Hispanic White	265
Black	662
Hispanic	15
Asian	17
Other	0
Native American	0

**Age**
From 65 to 74	375
From 75 to 84	368
85 and over	129
Less than 65	103

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2021

Hypertension	75
High Cholesterol	69
Stroke	8
Ischemic Heart Disease	39
Depression	15
Chronic Kidney Disease	53
Asthma	10
Osteoperosis	9
Atrial Fibrilation	12
Heart Failure	23
Chronic Obstructive Pulmonary Disease	15
Diabetes	47
Dementia	13
Cancer	39

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

biological response modifier (BRM) therapy	459
blood draw	1603
chemotherapy	459
doctor visit	1956
hormone therapy	27
hospital care	53
inpatient care	53
lab tests	7696
minimally invasive procedures	782
port flush	63
thyroid function tests	49

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	348
Female	776

**Ethnicity**
Non-Hispanic White	308
Black	767
Hispanic	15
Asian	15
Other	19
Native American	0

**Age**
From 65 to 74	435
From 75 to 84	407
85 and over	168
Less than 65	114

Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD in 2022

Hypertension	75
High Cholesterol	75
Stroke	13
Ischemic Heart Disease	28
Depression	14
Chronic Kidney Disease	41
Asthma	12
Osteoperosis	13
Atrial Fibrilation	18
Heart Failure	19
Chronic Obstructive Pulmonary Disease	18
Diabetes	47
Dementia	8
Cancer	44

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Nicholas A. Demonaco, MD for Medicare patients.

The highest averages for the top procedures that Dr. Nicholas A. Demonaco, MD treated as a medical oncologist in Clinton, MD were lab tests, blood draw, minimally invasive procedures and chemotherapy.

biological response modifier (BRM) therapy	411
blood draw	1391
chemotherapy	411
doctor visit	1561
hormone therapy	28
hospital care	195
inpatient care	195
lab tests	7160
minimally invasive procedures	658
preventive care	35
thyroid function tests	57
vaccines	35

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Nicholas A. Demonaco, MD.

**Gender**
Male	324
Female	652

**Ethnicity**
Black / African American	637
Asian / Pacific Islander	8
Non-Hispanic White	300
Hispanic	10
Native American / Alaskan Native	0
Other	7

**Age**
75 to 84	349
85 and over	117
Less than 65	108
65 to 74	401

Average of Total of Conditions of Medicare patients treated by Dr. Nicholas A. Demonaco, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Nicholas A. Demonaco, MD treated were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension	68
High Cholesterol	59
Stroke	7
Ischemic Heart Disease	34
Depression	13
Chronic Kidney Disease	48
Asthma	10
Osteoporosis	8
Heart Failure	23
Chronic Obstructive Pulmonary Disease	15
Diabetes	44
Atrial Fibrillation	10
Cancer	34
Dementia	11

Education & Training

Dr. Nicholas A. Demonaco, MD graduated from Temple University School of Medicine. He completed residency at University of Pittsburgh Medical Center (UPMC). He is certified by the American Board of Internal Medicine, Medical Oncology and has a state license in Maryland.

Medical School: Temple University School of Medicine

Residency: University of Pittsburgh Medical Center (UPMC)

Board Certification: American Board of Internal Medicine, Medical Oncology

Licensed In: Maryland

Affiliations & Hospitals

Dr. Nicholas A. Demonaco, MD is associated with these hospitals and organizations:

University of Maryland Medical System

Luminis Health

MedStar Health

MedStar Southern Maryland Hospital Center

MARYLAND ONCOLOGY HEMATOLOGY PA

Ratings & Reviews

Dr. Nicholas A. Demonaco, MD does not have any reviews yet, be the first to leave a review of Dr. Nicholas A. Demonaco, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Nicholas A. Demonaco, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Novartis Pharmaceuticals Corporation	$1,359 TASIGNA $378	TABRECTA $159	PROMACTA $137	NON BRAND $111	RYDAPT $91	Other $484
Janssen Biotech, Inc.	$831 IMBRUVICA $231	DARZALEX $198	Erleada $89	RYBREVANT $63	TALVEY $38	Other $212
Genentech USA, Inc.	$698 Avastin $137	Perjeta $123	Venclexta $104	POLIVY $81	Phesgo $73	Other $181
Daiichi Sankyo Inc.	$516 Enhertu $453	Injectafer $63
Pfizer Inc.	$497 IBRANCE $121	LORBRENA $98	RETACRIT $47	OXBRYTA $37	BOSULIF $33	Other $162
Other	$6,932 KEYTRUDA $344	IMBRUVICA $238	ELIQUIS $229	Venclexta $211	PADCEV $210	Other $5,699

**Types of Payments**
Food and Beverage	$10,711
Education	$123

Research Payments

Dr. Nicholas A. Demonaco, MD has received 16 research payments totaling $35,495.

Biography

Dr. Nicholas Demonaco's areas of specialization are adult hematology, adult oncology, and medical oncology; he sees patients in Clinton, MD and Largo, MD. These areas are among his clinical interests: bladder cancer, thyroid cancer, and bone marrow aspiration. He is a graduate of Temple University School of Medicine. Dr. Demonaco trained at the University of Pittsburgh Medical Center (UPMC) for residency. Dr. Demonaco's professional affiliations include the University of Maryland Medical System, MedStar Southern Maryland Hospital Center, and Luminis Health.